Clinical trial
An Ambidirectional Cohort Study on Treatment Strategies for Osteochondritis Dissecans of the Knee
NCT07439107 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Ambidirectional Cohort Study on Treatment Strategies for Osteochondritis Dissecans of the Knee
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 1, 2026
- Completion date
- December 31, 2028
- Enrollment
- 254 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteochondritis dissecans (ocd), osteochondritis dissecans knee